3D Medicines Inc. (HKG:1244)
Hong Kong · Delayed Price · Currency is HKD 2.390
+0.080 (3.46%)
Oct 9, 2026, 1:39 PM HKT
3D Medicines Cash Flow Statement
Financials in millions CNY. Fiscal year is January - December.
Millions CNY. Fiscal year is Jan - Dec.
Operating Activities
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Jun '26 Jun 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Net Income | -173.41 | -177.53 | -182.66 | -524.7 | -1,024 | -1,434 |
Depreciation & Amortization | 13.4 | 15.06 | 25.15 | 25.36 | 21.5 | 12.51 |
Other Amortization | 0.1 | 0.1 | 0.1 | 0.1 | 0.1 | 0.08 |
Loss (Gain) From Sale of Assets | -0.1 | 0 | -0.01 | - | - | 0.96 |
Asset Writedown & Restructuring Costs | - | - | 4.07 | - | - | - |
Loss (Gain) From Sale of Investments | 5.82 | 4.17 | 1.14 | -8.22 | 658.18 | 954.69 |
Stock-Based Compensation | 8.08 | 24.81 | 32.67 | 298.96 | 141.69 | 164.66 |
Other Operating Activities | -1.59 | -15.82 | -45.61 | -46.91 | -68.55 | -36.01 |
Change in Accounts Receivable | 33.7 | 27.32 | -42.66 | 72.71 | -13.06 | -65.13 |
Change in Inventory | -3 | 0.55 | 0.55 | -3.42 | -1.18 | -0.01 |
Change in Accounts Payable | 16.71 | 38.05 | -20.77 | 56.02 | 12.14 | 1.33 |
Change in Unearned Revenue | 4 | - | -24.54 | 24.54 | - | - |
Change in Other Net Operating Assets | 87.52 | -75.98 | 41.98 | -38.86 | -5.24 | 23.94 |
Operating Cash Flow | -8.78 | -159.26 | -210.58 | -144.41 | -278.78 | -377.08 |
Operating Cash Flow Growth | - | - | - | - | - | - |
Investing Activities
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Jun '26 Jun 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Capital Expenditures | -0.55 | -0.02 | -45.36 | -6.32 | -53.98 | -43.87 |
Sale of Property, Plant & Equipment | 0.13 | - | 0.03 | - | - | - |
Sale (Purchase) of Intangibles | - | - | - | - | - | -1.01 |
Investment in Securities | 90.36 | 70.57 | 52.46 | -187.68 | -194.2 | -49.58 |
Other Investing Activities | 3.87 | -92.01 | 10.82 | 6.43 | 6.07 | -4.41 |
Investing Cash Flow | 93.81 | -21.47 | 17.95 | -187.58 | -242.11 | -98.87 |
Financing Activities
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Jun '26 Jun 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Long-Term Debt Issued | - | 121.46 | 261.35 | 242.6 | 149.04 | - |
Total Debt Issued | 148.94 | 121.46 | 261.35 | 242.6 | 149.04 | - |
Long-Term Debt Repaid | - | -216.44 | -292.52 | -170.22 | -31.53 | -9.25 |
Lease Payments | -7.32 | -5.61 | -13.45 | -20.8 | -12.39 | -5.73 |
Total Debt Repaid | -160.92 | -216.44 | -292.52 | -170.22 | -31.53 | -9.25 |
Net Debt Issued (Repaid) | -11.98 | -94.98 | -31.17 | 72.38 | 117.51 | -9.25 |
Issuance of Common Stock | 0.73 | 1.24 | - | 219.22 | 315.13 | 6.02 |
Repurchase of Common Stock | - | - | -0.27 | -0.04 | -0.04 | -32.73 |
Other Financing Activities | 11.37 | 1.8 | -2.49 | 12.95 | -24.19 | -534.21 |
Financing Cash Flow | 0.12 | -91.94 | -33.92 | 304.51 | 408.41 | 840.08 |
Net Cash Flow
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Jun '26 Jun 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Foreign Exchange Rate Adjustments | -4.08 | -1.42 | 4.39 | -2.79 | 34.91 | -4.09 |
Net Cash Flow | 81.07 | -274.08 | -222.15 | -30.27 | -77.57 | 360.05 |
Free Cash Flow
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Jun '26 Jun 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Free Cash Flow | -9.33 | -159.28 | -255.94 | -150.74 | -332.76 | -420.95 |
Free Cash Flow Growth | - | - | - | - | - | - |
Free Cash Flow Margin | -2.61% | -44.73% | -57.43% | -23.74% | -58.65% | -698.56% |
Free Cash Flow Per Share | -0.04 | -0.65 | -1.04 | -0.66 | -7.32 | -10.78 |
Levered Free Cash Flow | 54.15 | -101.16 | -186.63 | 119.74 | -120.65 | -192.3 |
Unlevered Free Cash Flow | 56.87 | -97.9 | -180.69 | 124.6 | -118.7 | -191.35 |
Free Cash Flow After Leases | -16.65 | -164.9 | -269.39 | -171.54 | -345.15 | -426.68 |
Additional Metrics
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Jun '26 Jun 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Cash Interest Paid | - | - | - | - | 1.91 | 1.53 |
Cash Income Tax Paid | - | 0.08 | - | - | - | - |
Change in Working Capital | 138.93 | -10.06 | -45.43 | 110.99 | -7.35 | -39.88 |